These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7070584)

  • 1. Muscle fibre size and shape in Duchenne muscular dystrophy.
    Watkins SC; Cullen MJ
    Neuropathol Appl Neurobiol; 1982; 8(1):11-7. PubMed ID: 7070584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical fibre typing and ultrastructure of the small fibres in Duchenne muscular dystrophy.
    Watkins SC; Cullen MJ
    Neuropathol Appl Neurobiol; 1985; 11(6):447-60. PubMed ID: 2936970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Becker and Duchenne muscular dystrophy: a comparative morphological study.
    Dennett X; Shield LK; Clingan LJ; Woolley DA
    Aust Paediatr J; 1988; 24 Suppl 1():15-20. PubMed ID: 3202735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study.
    Cros D; Harnden P; Pellissier JF; Serratrice G
    J Neurol; 1989 Jan; 236(1):43-7. PubMed ID: 2915226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.
    Bernasconi P; Torchiana E; Confalonieri P; Brugnoni R; Barresi R; Mora M; Cornelio F; Morandi L; Mantegazza R
    J Clin Invest; 1995 Aug; 96(2):1137-44. PubMed ID: 7635950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
    Miike T
    Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis.
    Watkins SC; Cullen MJ
    J Neurol Sci; 1987 Dec; 82(1-3):181-92. PubMed ID: 3440865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of abnormal histochemical fibre type differentitation in human muscle biopsies.
    Johnson MA; Kucukyalcin DK
    J Neurol Sci; 1978 Jul; 37(3):159-78. PubMed ID: 150455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of muscle fibers typing on Duchenne muscular dystrophy].
    Gao FQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):273-7, 316. PubMed ID: 1291247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of connective tissue growth factor in progressive muscular dystrophy].
    Sun GL; Yao F; Jiang HK; Li P; Kazuhiro H
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):753-7. PubMed ID: 16255854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localisation of complement components C8 and C9 in human diseased muscle. The role of complement in muscle fibre damage.
    Sewry CA; Dubowitz V; Abraha A; Luzio JP; Campbell AK
    J Neurol Sci; 1987 Nov; 81(2-3):141-53. PubMed ID: 3694223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal fibre splitting in muscular dystrophy: a serial cinematographic study.
    Isaacs ER; Bradley WG; Henderson G
    J Neurol Neurosurg Psychiatry; 1973 Oct; 36(5):813-9. PubMed ID: 4753877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle lipids in Duchenne muscular dystrophy.
    Pearce PH; Johnsen RD; Wysocki SJ; Kakulas BA
    Aust J Exp Biol Med Sci; 1981 Feb; 59(1):77-90. PubMed ID: 7236123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
    Nicholson LV; Johnson MA; Gardner-Medwin D; Bhattacharya S; Harris JB
    Acta Neuropathol; 1990; 80(3):239-50. PubMed ID: 2205076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological properties of skinned fibres from normal and dystrophic (Duchenne) human muscle activated by Ca2+ and Sr2+.
    Fink RH; Stephenson DG; Williams DA
    J Physiol; 1990 Jan; 420():337-53. PubMed ID: 2324989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle.
    Delaporte C; Dehaupas M; Fardeau M
    J Neurol Sci; 1984 May; 64(2):149-60. PubMed ID: 6747662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy.
    Oexle K; Zwirner A; Freudenberg K; Kohlschütter A; Speer A
    Pediatr Res; 1997 Aug; 42(2):226-31. PubMed ID: 9262227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation.
    Maunder-Sewry CA; Dubowitz V
    J Neurol Sci; 1981 Feb; 49(2):305-24. PubMed ID: 6452514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.